课题基金 / 基金详情

Impact of early life seizures on glutamate receptors and synaptic function

Impact of early life seizures on glutamate receptors and synaptic function
早期癫痫发作对谷氨酸受体和突触功能的影响
批准号:
7591131
负责人:
TIMOTHY A BENKE
金额:
$18.74万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2012-04-30

项目摘要

项目成果

TIMOTHY A BENKE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):临床证据表明,婴儿和儿童癫痫发作会导致长期学习障碍。然而,在实验室研究中,提出的机制是不一致的,部分原因是不同的实验范式。调节学习和记忆的突触特性(长时程增强(LTP)和长时程抑制(LTD))随着发育而变化。这些过程涉及由特定NMDA受体(NR)亚基触发的谷氨酸受体(GluR)亚基的改变。我们的行为数据表明,大鼠早期癫痫发作(ELS)的一次发作会导致后来的学习障碍。这种情况不会改变神经元的形态和连接。体外研究显示海马LTP和LTD的改变与谷氨酸受体的异常调节一致。相反,以前的生化研究表明孤立的下调GluR2,我们的电生理数据表明突触GluR1短暂上调后不久,ELS,但后来在内部池举行。NR2A的总表达永久性降低。我们假设GluR1的瞬时上调巩固了异常的发育轨迹。这种轨迹导致GluR1和NR2A的进一步异常调节,随后介导异常LTP和LTD以及我们在ELS后观察到的学习障碍。亚突触机制的异常表达调节GluR1和NR2A的这些改变,并使长期效应硬连线。目前,对于这种常见的、使人衰弱的和昂贵的病症,临床上没有可用的治疗干预。彻底表征是什么使未成熟的兴奋性突触容易受到早期癫痫发作的影响,以及由此产生的长期持续的变化,将为这种缺陷以及发育中的突触的神经生物学提供有价值的见解。为了验证我们的假设和解决相反的意见,我们提出了三个具体的目标,涉及在体外电生理和生化研究大鼠:具体目标1(SA1):表达同型GluR1受体在发展早期使CA1海马突触易受ELS。特异性目的2(SA2):ELS导致GluR1和NR2A受体表达的快速、持续变化,这与正常发育相反。特定目的3(SA3):ELS后GluR1和NR2A受体表达的持续变化由突触下机制表达的改变介导。这些目标将提供必要的证据,以支持未来的R01资助的机制研究,解决药理学干预,可以防止ELS对学习障碍的影响。
英文摘要
DESCRIPTION (provided by applicant): Clinical evidence demonstrates that seizures in infants and children cause long-term learning disabilities. However in laboratory studies, the proposed mechanisms for this are inconsistent, partly due to different experimental paradigms. Synaptic properties mediating learning and memory (long-term potentiation (LTP) and long-term depression (LTD)) change with development. These processes involve alterations in glutamate receptor (GluR) subunits that are triggered by specific NMDA receptor (NR) subunits. Our behavioral data demonstrate that a single episode of early-life seizures (ELS) in rats causes later learning disability. This occurs without alteration of neuronal morphology and connections. In vitro studies show alterations in hippocampal LTP and LTD that are consistent with abnormal regulation of glutamate receptors. Contrary to prior biochemical studies suggesting isolated down-regulation of GluR2, our electrophysiological data suggests synaptic GluR1 is transiently up-regulated shortly after ELS but later held in internal pools. Total expression of NR2A becomes permanently decreased. We hypothesize that the transient up-regulation of GluR1 consolidates an abnormal developmental trajectory. This trajectory leads to further abnormal regulation of GluR1 and NR2A that subsequently mediates the abnormal LTP and LTD and the learning disability that we observe following ELS. Abnormal expression of sub-synaptic machinery regulates these alterations in GluR1 and NR2A and hard-wires the long term effects. Currently, there are no therapeutic interventions clinically available for this common, debilitating and costly condition. Thorough characterization of both what makes immature excitatory synapses vulnerable to early-life seizures and the resulting long lasting changes will provide valuable insight into this deficiency as well as the neurobiology of developing synapses. To test our hypothesis and resolve contrary observations we propose three Specific Aims involving in vitro electrophysiological and biochemical studies in rats: Specific Aim 1 (SA1): Expression of homomeric GluR1 receptors early in development makes CA1 hippocampal synapses vulnerable to ELS. Specifc Aim 2 (SA2): ELS causes a rapid, persistent alteration of expression of GluR1 and NR2A receptors that is contrary to normal development. Specific Aim 3 (SA3): The persistent alteration of expression of GluR1 and NR2A receptors following ELS is mediated by altered expression of sub-synaptic machinery. These Aims will provide the evidence necessary to support future R01-funded mechanistic studies that address pharmacological interventions that could prevent the effects of ELS on learning impairment.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1152/jn.00099.2010
发表时间: 2010-10
期刊: Journal of neurophysiology
影响因子: 2.5
作者: [E. Stubblefield;T. Benke]
通讯作者: E. Stubblefield;T. Benke
University of Colorado Rocky Mountain NeuroNEXT (UNCOMON) Clinical Research Consortium.
  • 批准号:
    10744629
  • 项目类别:
  • 资助金额:
    $42.9万
  • 财政年份:
    2023
  • 负责人:
    TIMOTHY A BENKE
  • 依托单位:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
  • 批准号:
    10569019
  • 项目类别:
  • 资助金额:
    $90.23万
  • 财政年份:
    2021
  • 负责人:
    TIMOTHY A BENKE
  • 依托单位:
Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder
  • 批准号:
    10338135
  • 项目类别:
  • 资助金额:
    $92.42万
  • 财政年份:
    2021
  • 负责人:
    TIMOTHY A BENKE
  • 依托单位:
Exploratory determination of the role of L-type calcium channels in mediating abnormal plasticity and behavior after early life seizures
  • 批准号:
    9454781
  • 项目类别:
  • 资助金额:
    $18.99万
  • 财政年份:
    2017
  • 负责人:
    TIMOTHY A BENKE
  • 依托单位:
国内基金
海外基金
Behavioral Insights on Cooperation in Social Dilemmas
  • 批准号:
    --
  • 项目类别:
    外国优秀青年学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    LIEN,Jaimie Wei-Hung
  • 依托单位: